The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of recombinant interleukin 15 in combination with nivolumab and ipilimumab in subjects with refractory cancers.
 
Jibran Ahmed
No Relationships to Disclose
 
Geraldine O'Sullivan Coyne
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - Novartis Ireland Ltd.
 
Ashley Bruns
No Relationships to Disclose
 
Lawrence Rubinstein
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
Sarah Shin
No Relationships to Disclose
 
Jessica Mukherjee
No Relationships to Disclose
 
Kristin Fino
No Relationships to Disclose
 
King Fung
No Relationships to Disclose
 
Katherine Ferry-Galow
No Relationships to Disclose
 
Ralph Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - Leidos; SciTech Development LLC
Consulting or Advisory Role - SciTech Development Inc
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; named inventor on EU patent EP3430051B1; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
 
Barry Johnson
No Relationships to Disclose
 
Howard Streicher
No Relationships to Disclose
 
James Doroshow
No Relationships to Disclose
 
Alice Chen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)